

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.69249683 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.69249683 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.69249683 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.69249683 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.69249683 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.69249683 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.91378760 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.43641191 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.43641191 |
| 10 | response to host immune response (GO:0052572) | 5.42577773 |
| 11 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.42577773 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.38845075 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.30160746 |
| 14 | microglial cell activation (GO:0001774) | 4.97914340 |
| 15 | * response to peptidoglycan (GO:0032494) | 4.97390286 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.92968820 |
| 17 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.89919964 |
| 18 | response to host (GO:0075136) | 4.89919964 |
| 19 | response to host defenses (GO:0052200) | 4.89919964 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.61024791 |
| 21 | cellular extravasation (GO:0045123) | 4.54305090 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49374033 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 4.44354921 |
| 24 | detection of bacterium (GO:0016045) | 4.34194468 |
| 25 | respiratory burst (GO:0045730) | 4.34055702 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 4.27719704 |
| 27 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.25863770 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.24467960 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.14490344 |
| 30 | macrophage activation (GO:0042116) | 4.07680353 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06983913 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.03889629 |
| 33 | granulocyte activation (GO:0036230) | 3.99584124 |
| 34 | detection of biotic stimulus (GO:0009595) | 3.94545358 |
| 35 | myeloid cell activation involved in immune response (GO:0002275) | 3.93431539 |
| 36 | neutrophil activation (GO:0042119) | 3.93259462 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.85222544 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84198793 |
| 39 | regulation of mast cell degranulation (GO:0043304) | 3.82265356 |
| 40 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.76754140 |
| 41 | positive regulation of mast cell degranulation (GO:0043306) | 3.71602498 |
| 42 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.71602498 |
| 43 | regulation of mast cell activation (GO:0033003) | 3.71167518 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.71053363 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67317071 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.67070503 |
| 47 | regulation of mononuclear cell migration (GO:0071675) | 3.63422658 |
| 48 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.63095583 |
| 49 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.62235014 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.61920867 |
| 51 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60393993 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.59782744 |
| 53 | negative regulation of mast cell activation (GO:0033004) | 3.54350236 |
| 54 | negative regulation of interleukin-17 production (GO:0032700) | 3.54212455 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51937300 |
| 56 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.49916684 |
| 57 | leukocyte aggregation (GO:0070486) | 3.48358561 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.47119639 |
| 59 | response to muramyl dipeptide (GO:0032495) | 3.44951769 |
| 60 | lymphocyte chemotaxis (GO:0048247) | 3.44912924 |
| 61 | germinal center formation (GO:0002467) | 3.43087114 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34143259 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.33590918 |
| 64 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.30267877 |
| 65 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.30237200 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.30180298 |
| 67 | positive regulation of interferon-beta production (GO:0032728) | 3.29118483 |
| 68 | positive regulation of macrophage cytokine production (GO:0060907) | 3.27680815 |
| 69 | regulation of antigen processing and presentation (GO:0002577) | 3.27030848 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.26216088 |
| 71 | defense response to protozoan (GO:0042832) | 3.25311787 |
| 72 | positive regulation of lymphocyte migration (GO:2000403) | 3.25040034 |
| 73 | eosinophil chemotaxis (GO:0048245) | 3.24651429 |
| 74 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22278291 |
| 75 | regulation of cholesterol storage (GO:0010885) | 3.22140506 |
| 76 | B cell mediated immunity (GO:0019724) | 3.21735470 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.21408110 |
| 78 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.19725139 |
| 79 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.19333100 |
| 80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.19007153 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18808727 |
| 82 | negative regulation of interleukin-1 production (GO:0032692) | 3.17713763 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 3.17660300 |
| 84 | * neutrophil chemotaxis (GO:0030593) | 3.16363320 |
| 85 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.16282452 |
| 86 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15297600 |
| 87 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.14822899 |
| 88 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.14619619 |
| 89 | regulation of tolerance induction (GO:0002643) | 3.14508098 |
| 90 | I-kappaB phosphorylation (GO:0007252) | 3.14269898 |
| 91 | pinocytosis (GO:0006907) | 3.12817242 |
| 92 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.11757162 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 3.11324665 |
| 94 | negative regulation of interleukin-6 production (GO:0032715) | 3.09721076 |
| 95 | superoxide anion generation (GO:0042554) | 3.08995561 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08465827 |
| 97 | * neutrophil migration (GO:1990266) | 3.07146733 |
| 98 | leukocyte degranulation (GO:0043299) | 3.06941548 |
| 99 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.06571836 |
| 100 | detection of other organism (GO:0098543) | 3.02456115 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.02203315 |
| 102 | response to protozoan (GO:0001562) | 3.01380326 |
| 103 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00328621 |
| 104 | regulation of regulated secretory pathway (GO:1903305) | 2.99516264 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98906542 |
| 106 | type I interferon signaling pathway (GO:0060337) | 2.98461171 |
| 107 | cellular response to type I interferon (GO:0071357) | 2.98461171 |
| 108 | eosinophil migration (GO:0072677) | 2.97154511 |
| 109 | * granulocyte chemotaxis (GO:0071621) | 2.96713459 |
| 110 | regulation of macrophage cytokine production (GO:0010935) | 2.96615974 |
| 111 | response to type I interferon (GO:0034340) | 2.95699311 |
| 112 | myeloid leukocyte activation (GO:0002274) | 2.94021907 |
| 113 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.92144346 |
| 114 | response to interleukin-15 (GO:0070672) | 2.91358230 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.90285074 |
| 116 | leukotriene metabolic process (GO:0006691) | 2.90023718 |
| 117 | * granulocyte migration (GO:0097530) | 2.84973837 |
| 118 | regulation of lymphocyte migration (GO:2000401) | 2.84774689 |
| 119 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.84678274 |
| 120 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82779603 |
| 121 | tolerance induction (GO:0002507) | 2.82547445 |
| 122 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.79705840 |
| 123 | regulation of interleukin-17 production (GO:0032660) | 2.79426195 |
| 124 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.79014726 |
| 125 | regulation of macrophage chemotaxis (GO:0010758) | 2.78860267 |
| 126 | reactive oxygen species biosynthetic process (GO:1903409) | 2.78112530 |
| 127 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.77355971 |
| 128 | regulation of monocyte chemotaxis (GO:0090025) | 2.76731258 |
| 129 | phagocytosis, engulfment (GO:0006911) | 2.76076571 |
| 130 | leukocyte mediated cytotoxicity (GO:0001909) | 2.75552398 |
| 131 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75003030 |
| 132 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.74834451 |
| 133 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.72836042 |
| 134 | myeloid leukocyte mediated immunity (GO:0002444) | 2.72398114 |
| 135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72215508 |
| 136 | T-helper 1 type immune response (GO:0042088) | 2.71380166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.23097852 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.13498900 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.36451511 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.92084557 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.65843759 |
| 6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.99179515 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.87627253 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42682483 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.31555010 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.01591530 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.96317640 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.86688274 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.84089656 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.74855250 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71075850 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.65244604 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64065152 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50974350 |
| 19 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.47264192 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25827874 |
| 21 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.17791258 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15852034 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06708201 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99820886 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96795031 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96536551 |
| 27 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94383909 |
| 28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.90118401 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83689341 |
| 30 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.82422579 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.79278017 |
| 32 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76769888 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72606367 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70695142 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68552229 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61601291 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60413609 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53405339 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51458980 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.51191695 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51180780 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49679824 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.49220333 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48535831 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47808892 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.42930733 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41423562 |
| 48 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39720358 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36423111 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33839636 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.33284268 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30520220 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27039602 |
| 54 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26885490 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25592646 |
| 56 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24452179 |
| 57 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22992554 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22673599 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17229607 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16157027 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12528809 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11480964 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09305530 |
| 64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08899021 |
| 65 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08782513 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08144561 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08085133 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.07334425 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05512685 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04923805 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04326979 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02262420 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00444109 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99567034 |
| 75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97610933 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97475050 |
| 77 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.97175035 |
| 78 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96963852 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93391554 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92961401 |
| 81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90788219 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90725133 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90144024 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89714382 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87494631 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87404084 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86994800 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85436004 |
| 89 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84558559 |
| 90 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83703971 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81739148 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79493804 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78543177 |
| 94 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77267717 |
| 95 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.77167780 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76311387 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.75122713 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74614691 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74477654 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74421535 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.73906324 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.73362192 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70813994 |
| 104 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69926206 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69843299 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69053570 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68143047 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68143047 |
| 109 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68039931 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.68032782 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.67917299 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67894170 |
| 113 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67551295 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 0.65373166 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65318541 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64876256 |
| 117 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64473429 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.64348163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.68605752 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.00885287 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.79952013 |
| 4 | MP0003303_peritoneal_inflammation | 3.65366121 |
| 5 | MP0009785_altered_susceptibility_to | 3.51741624 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.46356187 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.44228241 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.17514201 |
| 9 | MP0006082_CNS_inflammation | 3.11083387 |
| 10 | MP0003724_increased_susceptibility_to | 3.03996344 |
| 11 | MP0009278_abnormal_bone_marrow | 2.84571230 |
| 12 | * MP0005025_abnormal_response_to | 2.74541381 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.65953823 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.64729633 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.48874696 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.47433509 |
| 17 | MP0000343_altered_response_to | 2.47071773 |
| 18 | MP0001790_abnormal_immune_system | 2.45749003 |
| 19 | MP0005387_immune_system_phenotype | 2.45749003 |
| 20 | MP0002723_abnormal_immune_serum | 2.26484756 |
| 21 | * MP0001800_abnormal_humoral_immune | 2.24781028 |
| 22 | MP0004510_myositis | 2.22864814 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.13632944 |
| 24 | MP0009840_abnormal_foam_cell | 2.10991088 |
| 25 | MP0003075_altered_response_to | 2.02360001 |
| 26 | * MP0001819_abnormal_immune_cell | 2.01450626 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 2.00637980 |
| 28 | MP0009764_decreased_sensitivity_to | 1.97731685 |
| 29 | MP0002405_respiratory_system_inflammati | 1.97400177 |
| 30 | MP0000685_abnormal_immune_system | 1.95691292 |
| 31 | MP0005671_abnormal_response_to | 1.90224881 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.88646850 |
| 33 | MP0001853_heart_inflammation | 1.87399280 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.86226128 |
| 35 | MP0003448_altered_tumor_morphology | 1.84818767 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.82426671 |
| 37 | MP0003690_abnormal_glial_cell | 1.82337137 |
| 38 | MP0000604_amyloidosis | 1.81878891 |
| 39 | MP0008469_abnormal_protein_level | 1.68223275 |
| 40 | MP0003828_pulmonary_edema | 1.66254161 |
| 41 | MP0004947_skin_inflammation | 1.66057921 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.59651008 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.59651008 |
| 44 | MP0005451_abnormal_body_composition | 1.57695530 |
| 45 | MP0002132_abnormal_respiratory_system | 1.50554866 |
| 46 | MP0005310_abnormal_salivary_gland | 1.45432196 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.44689332 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.44164012 |
| 49 | MP0005166_decreased_susceptibility_to | 1.41162962 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.40416381 |
| 51 | MP0000858_altered_metastatic_potential | 1.39490244 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.38833901 |
| 53 | MP0000716_abnormal_immune_system | 1.37092042 |
| 54 | MP0008004_abnormal_stomach_pH | 1.34626407 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.33529243 |
| 56 | MP0005390_skeleton_phenotype | 1.29701639 |
| 57 | MP0002933_joint_inflammation | 1.28445713 |
| 58 | MP0005164_abnormal_response_to | 1.26914794 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.24096050 |
| 60 | MP0002398_abnormal_bone_marrow | 1.21640482 |
| 61 | MP0004883_abnormal_blood_vessel | 1.20392029 |
| 62 | * MP0000689_abnormal_spleen_morphology | 1.17579265 |
| 63 | MP0000569_abnormal_digit_pigmentation | 1.17517378 |
| 64 | MP0003763_abnormal_thymus_physiology | 1.16006923 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.11984298 |
| 66 | MP0002429_abnormal_blood_cell | 1.10857073 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.06904380 |
| 68 | MP0001851_eye_inflammation | 1.06831344 |
| 69 | MP0002254_reproductive_system_inflammat | 1.01258063 |
| 70 | MP0003866_abnormal_defecation | 0.99294707 |
| 71 | MP0002722_abnormal_immune_system | 0.99213848 |
| 72 | MP0002006_tumorigenesis | 0.93052561 |
| 73 | MP0010307_abnormal_tumor_latency | 0.92009593 |
| 74 | MP0003566_abnormal_cell_adhesion | 0.91943472 |
| 75 | * MP0009763_increased_sensitivity_to | 0.91481883 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.91390355 |
| 77 | MP0000249_abnormal_blood_vessel | 0.87704244 |
| 78 | MP0005174_abnormal_tail_pigmentation | 0.87202969 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.85459197 |
| 80 | MP0005023_abnormal_wound_healing | 0.85343820 |
| 81 | MP0003195_calcinosis | 0.83874759 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.82378654 |
| 83 | MP0004381_abnormal_hair_follicle | 0.82228049 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.77517054 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.76801357 |
| 86 | MP0003279_aneurysm | 0.76619880 |
| 87 | MP0000920_abnormal_myelination | 0.75220229 |
| 88 | MP0008260_abnormal_autophagy | 0.75155060 |
| 89 | MP0003795_abnormal_bone_structure | 0.73749330 |
| 90 | MP0006054_spinal_hemorrhage | 0.70867123 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.70784743 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.70462595 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.70399363 |
| 94 | MP0008438_abnormal_cutaneous_collagen | 0.66522544 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.66042396 |
| 96 | MP0003329_amyloid_beta_deposits | 0.65226227 |
| 97 | MP0002139_abnormal_hepatobiliary_system | 0.62346579 |
| 98 | MP0003045_fibrosis | 0.62262018 |
| 99 | MP0008874_decreased_physiological_sensi | 0.62046699 |
| 100 | MP0003091_abnormal_cell_migration | 0.61497464 |
| 101 | MP0000490_abnormal_crypts_of | 0.60650068 |
| 102 | MP0005165_increased_susceptibility_to | 0.58621361 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.57580417 |
| 104 | MP0003186_abnormal_redox_activity | 0.57418457 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.56652600 |
| 106 | MP0000767_abnormal_smooth_muscle | 0.55488067 |
| 107 | MP0008873_increased_physiological_sensi | 0.55311728 |
| 108 | MP0000609_abnormal_liver_physiology | 0.53098241 |
| 109 | MP0001663_abnormal_digestive_system | 0.52303637 |
| 110 | MP0001958_emphysema | 0.51769406 |
| 111 | MP0003950_abnormal_plasma_membrane | 0.51606333 |
| 112 | MP0001873_stomach_inflammation | 0.49803378 |
| 113 | MP0004130_abnormal_muscle_cell | 0.48833640 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.48813822 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48477092 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.48347415 |
| 117 | MP0000371_diluted_coat_color | 0.48273098 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.47592627 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.46059315 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.45449768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.96422542 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 7.22550185 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.69128603 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.32309850 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.91812757 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.66056697 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.41411508 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 5.36385460 |
| 9 | Glomerulonephritis (HP:0000099) | 5.16982051 |
| 10 | Abnormality of macrophages (HP:0004311) | 5.13091372 |
| 11 | Stomatitis (HP:0010280) | 4.63569932 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.31854579 |
| 13 | Dysostosis multiplex (HP:0000943) | 4.27636724 |
| 14 | Gingivitis (HP:0000230) | 4.08447807 |
| 15 | Myositis (HP:0100614) | 4.08258392 |
| 16 | Orchitis (HP:0100796) | 4.08011583 |
| 17 | Disinhibition (HP:0000734) | 4.04847494 |
| 18 | Obstructive lung disease (HP:0006536) | 3.95259302 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.95259302 |
| 20 | Abnormality of complement system (HP:0005339) | 3.89652444 |
| 21 | Axonal loss (HP:0003447) | 3.80536889 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.77654481 |
| 23 | Optic neuritis (HP:0100653) | 3.77654481 |
| 24 | Recurrent skin infections (HP:0001581) | 3.75514903 |
| 25 | Prostate neoplasm (HP:0100787) | 3.72024475 |
| 26 | Complement deficiency (HP:0004431) | 3.69220243 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.50185690 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43467491 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.39394443 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.37345813 |
| 31 | Thick nail (HP:0001805) | 3.33714778 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.30958872 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.30958872 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26600440 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26600440 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26600440 |
| 37 | Nephritis (HP:0000123) | 3.19001260 |
| 38 | Pustule (HP:0200039) | 3.18750242 |
| 39 | Spontaneous hematomas (HP:0007420) | 3.17260134 |
| 40 | Agnosia (HP:0010524) | 3.16642117 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.14725477 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.14725477 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.14725477 |
| 44 | Hemoptysis (HP:0002105) | 3.06898995 |
| 45 | Urticaria (HP:0001025) | 3.02491169 |
| 46 | Recurrent fungal infections (HP:0002841) | 3.00637882 |
| 47 | Episodic fever (HP:0001954) | 2.98872330 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95258221 |
| 49 | Increased IgE level (HP:0003212) | 2.89057886 |
| 50 | Basal ganglia calcification (HP:0002135) | 2.80333333 |
| 51 | Cellulitis (HP:0100658) | 2.74984021 |
| 52 | Hepatosplenomegaly (HP:0001433) | 2.71412659 |
| 53 | Periodontitis (HP:0000704) | 2.70282159 |
| 54 | Myocardial infarction (HP:0001658) | 2.68365268 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.65466316 |
| 56 | Chest pain (HP:0100749) | 2.63779725 |
| 57 | Hematochezia (HP:0002573) | 2.62741204 |
| 58 | T lymphocytopenia (HP:0005403) | 2.60993335 |
| 59 | Increased serum ferritin (HP:0003281) | 2.60644666 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.59786236 |
| 61 | Pulmonary embolism (HP:0002204) | 2.58577306 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.58169309 |
| 63 | Recurrent viral infections (HP:0004429) | 2.57788194 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.55920244 |
| 65 | Vasculitis (HP:0002633) | 2.50200070 |
| 66 | Abnormality of T cell number (HP:0011839) | 2.47743987 |
| 67 | Meningitis (HP:0001287) | 2.46441722 |
| 68 | Progressive visual loss (HP:0000529) | 2.46221132 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.45153173 |
| 70 | Gangrene (HP:0100758) | 2.43340002 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.42476335 |
| 72 | Loss of speech (HP:0002371) | 2.41446500 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.34358390 |
| 74 | Osteomyelitis (HP:0002754) | 2.32386402 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31629938 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.31629938 |
| 77 | Increased IgM level (HP:0003496) | 2.31050208 |
| 78 | Polyneuropathy (HP:0001271) | 2.30425778 |
| 79 | Epistaxis (HP:0000421) | 2.30316858 |
| 80 | Hypochromic anemia (HP:0001931) | 2.29641188 |
| 81 | Peritonitis (HP:0002586) | 2.29530174 |
| 82 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.29005790 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.28145641 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.27473604 |
| 85 | Pathologic fracture (HP:0002756) | 2.26711218 |
| 86 | Recurrent pneumonia (HP:0006532) | 2.23469116 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.22801559 |
| 88 | Arterial thrombosis (HP:0004420) | 2.21087334 |
| 89 | Joint hemorrhage (HP:0005261) | 2.19583979 |
| 90 | Leukocytosis (HP:0001974) | 2.19449166 |
| 91 | Petechiae (HP:0000967) | 2.16704952 |
| 92 | Vertigo (HP:0002321) | 2.14162040 |
| 93 | J-shaped sella turcica (HP:0002680) | 2.11352143 |
| 94 | Mutism (HP:0002300) | 2.10184024 |
| 95 | Keratoconjunctivitis (HP:0001096) | 2.09837918 |
| 96 | Inappropriate behavior (HP:0000719) | 2.07822776 |
| 97 | Abnormality of the endocardium (HP:0004306) | 2.05183032 |
| 98 | Apathy (HP:0000741) | 2.04218834 |
| 99 | Diminished motivation (HP:0000745) | 2.04053778 |
| 100 | Colitis (HP:0002583) | 2.03582504 |
| 101 | Acne (HP:0001061) | 2.02758763 |
| 102 | Premature loss of primary teeth (HP:0006323) | 2.02360544 |
| 103 | Bone pain (HP:0002653) | 2.02344390 |
| 104 | Glomerulopathy (HP:0100820) | 2.02195305 |
| 105 | Chronic otitis media (HP:0000389) | 2.01195553 |
| 106 | Peripheral demyelination (HP:0011096) | 1.99865677 |
| 107 | Abnormality of T cells (HP:0002843) | 1.98063877 |
| 108 | Amyloidosis (HP:0011034) | 1.97987042 |
| 109 | Conjunctival telangiectasia (HP:0000524) | 1.97909292 |
| 110 | Inflammation of the large intestine (HP:0002037) | 1.95636096 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 1.94901627 |
| 112 | Progressive neurologic deterioration (HP:0002344) | 1.92249199 |
| 113 | Neuronal loss in central nervous system (HP:0002529) | 1.90513573 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90115066 |
| 115 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90115066 |
| 116 | Abnormality of the pericardium (HP:0001697) | 1.89642740 |
| 117 | Abnormality of the lumbar spine (HP:0100712) | 1.89310852 |
| 118 | Microcytic anemia (HP:0001935) | 1.88686162 |
| 119 | Keratitis (HP:0000491) | 1.88607498 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88227032 |
| 121 | Abnormality of the peritoneum (HP:0002585) | 1.88173727 |
| 122 | Thoracic kyphosis (HP:0002942) | 1.85028438 |
| 123 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84614402 |
| 124 | Neoplasm of head and neck (HP:0012288) | 1.80831404 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.80831404 |
| 126 | Asymmetric septal hypertrophy (HP:0001670) | 1.76984962 |
| 127 | Gastrointestinal inflammation (HP:0004386) | 1.76567180 |
| 128 | Personality changes (HP:0000751) | 1.76358627 |
| 129 | Sepsis (HP:0100806) | 1.73628611 |
| 130 | Gingival bleeding (HP:0000225) | 1.72325416 |
| 131 | Purpura (HP:0000979) | 1.71648945 |
| 132 | Anorexia (HP:0002039) | 1.71354429 |
| 133 | Vertebral compression fractures (HP:0002953) | 1.69557578 |
| 134 | Encephalitis (HP:0002383) | 1.69205376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 5.25431215 |
| 2 | IRAK4 | 4.14130808 |
| 3 | RIPK4 | 3.45822181 |
| 4 | TBK1 | 3.00591225 |
| 5 | MAP3K14 | 2.98363004 |
| 6 | TYK2 | 2.97018896 |
| 7 | IRAK3 | 2.92502594 |
| 8 | TGFBR2 | 2.90365709 |
| 9 | MAP4K1 | 2.78909628 |
| 10 | KIT | 2.51429782 |
| 11 | TXK | 2.39761808 |
| 12 | ERN1 | 2.35891893 |
| 13 | IKBKE | 2.06001067 |
| 14 | FGR | 1.96954968 |
| 15 | TNK2 | 1.96478773 |
| 16 | CSK | 1.95322937 |
| 17 | PRPF4B | 1.91535724 |
| 18 | IKBKB | 1.90082039 |
| 19 | GRK7 | 1.87944031 |
| 20 | EPHB1 | 1.81310948 |
| 21 | HCK | 1.77133009 |
| 22 | FES | 1.76697570 |
| 23 | STK10 | 1.65247156 |
| 24 | BTK | 1.64078665 |
| 25 | ZAP70 | 1.63574844 |
| 26 | CSF1R | 1.58565792 |
| 27 | TEC | 1.51824202 |
| 28 | JAK1 | 1.48828376 |
| 29 | MAP2K3 | 1.48124031 |
| 30 | LYN | 1.44088131 |
| 31 | SYK | 1.37077537 |
| 32 | JAK3 | 1.32303161 |
| 33 | CAMK1D | 1.26552061 |
| 34 | MAP3K3 | 1.26010128 |
| 35 | SIK3 | 1.25404691 |
| 36 | MATK | 1.21625620 |
| 37 | ITK | 1.18033929 |
| 38 | LCK | 1.11587424 |
| 39 | NEK9 | 1.10381938 |
| 40 | JAK2 | 1.02384768 |
| 41 | CAMKK2 | 0.97867476 |
| 42 | ACVR1B | 0.94906708 |
| 43 | TRPM7 | 0.94212468 |
| 44 | PIM2 | 0.92640262 |
| 45 | CHUK | 0.91424351 |
| 46 | MAP3K13 | 0.88850732 |
| 47 | MARK3 | 0.86156696 |
| 48 | MARK2 | 0.85625822 |
| 49 | DAPK2 | 0.85615051 |
| 50 | BMPR2 | 0.84718131 |
| 51 | TTN | 0.84649265 |
| 52 | PBK | 0.84228509 |
| 53 | RPS6KA4 | 0.83704002 |
| 54 | TAOK3 | 0.83166606 |
| 55 | CLK1 | 0.81103268 |
| 56 | ERBB3 | 0.80403344 |
| 57 | CDC42BPA | 0.80154626 |
| 58 | PIM1 | 0.79724457 |
| 59 | MAP3K11 | 0.79079004 |
| 60 | PAK4 | 0.77794456 |
| 61 | PDK1 | 0.77164899 |
| 62 | EGFR | 0.77060099 |
| 63 | MOS | 0.76519728 |
| 64 | PRKD2 | 0.76451579 |
| 65 | ADRBK2 | 0.74700466 |
| 66 | NME2 | 0.72552236 |
| 67 | CAMK1G | 0.71787097 |
| 68 | SIK2 | 0.71474490 |
| 69 | * PRKCD | 0.71372966 |
| 70 | ABL1 | 0.69691726 |
| 71 | LRRK2 | 0.66757813 |
| 72 | MAPK7 | 0.66142667 |
| 73 | MAP3K10 | 0.65994484 |
| 74 | KDR | 0.65942115 |
| 75 | EIF2AK2 | 0.64428210 |
| 76 | CAMKK1 | 0.63181759 |
| 77 | MAPK12 | 0.62953342 |
| 78 | TRIB3 | 0.57969631 |
| 79 | MAP2K6 | 0.57189738 |
| 80 | MAP3K2 | 0.56760958 |
| 81 | FYN | 0.56402379 |
| 82 | BMX | 0.56084869 |
| 83 | ABL2 | 0.55780991 |
| 84 | IRAK2 | 0.55370867 |
| 85 | MAP2K4 | 0.55165150 |
| 86 | PKN2 | 0.54113575 |
| 87 | PIK3CG | 0.53993114 |
| 88 | RPS6KC1 | 0.53081977 |
| 89 | RPS6KL1 | 0.53081977 |
| 90 | EPHA3 | 0.52557494 |
| 91 | GRK6 | 0.52205501 |
| 92 | PTK6 | 0.51520807 |
| 93 | MAP3K1 | 0.50975418 |
| 94 | MAP3K6 | 0.50713712 |
| 95 | MAP3K5 | 0.50401010 |
| 96 | SCYL2 | 0.49489262 |
| 97 | IRAK1 | 0.49425261 |
| 98 | YES1 | 0.48243150 |
| 99 | CDK6 | 0.48199241 |
| 100 | KSR2 | 0.47891059 |
| 101 | KSR1 | 0.47607598 |
| 102 | MAPKAPK2 | 0.46171982 |
| 103 | SGK3 | 0.46087024 |
| 104 | DYRK1B | 0.45494299 |
| 105 | STK11 | 0.44930843 |
| 106 | TAOK1 | 0.44426037 |
| 107 | IGF1R | 0.42685323 |
| 108 | PRKCQ | 0.42436514 |
| 109 | CDK19 | 0.42185187 |
| 110 | TESK2 | 0.40590760 |
| 111 | MAP3K12 | 0.39109262 |
| 112 | RIPK1 | 0.39018459 |
| 113 | DDR2 | 0.38996196 |
| 114 | TESK1 | 0.38642239 |
| 115 | DYRK3 | 0.37621560 |
| 116 | FGFR3 | 0.36830603 |
| 117 | PTK2B | 0.35729368 |
| 118 | MAPK4 | 0.34379623 |
| 119 | HIPK2 | 0.33981305 |
| 120 | TAOK2 | 0.33550657 |
| 121 | DMPK | 0.32574110 |
| 122 | MAP3K7 | 0.31263512 |
| 123 | PRKG2 | 0.30023242 |
| 124 | RAF1 | 0.29759441 |
| 125 | GSK3A | 0.29606868 |
| 126 | RPS6KA6 | 0.29070127 |
| 127 | RPS6KA1 | 0.28445947 |
| 128 | STK4 | 0.28296183 |
| 129 | RPS6KA2 | 0.28222137 |
| 130 | SGK2 | 0.27961161 |
| 131 | MST4 | 0.26050624 |
| 132 | MAP3K8 | 0.23692353 |
| 133 | PRKCH | 0.23215399 |
| 134 | PDPK1 | 0.23214524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.53943480 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.51839414 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.84314643 |
| 4 | Pertussis_Homo sapiens_hsa05133 | 2.77477981 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.73936377 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71387715 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.55508262 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.50264730 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.44471153 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.29125792 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25828463 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.23685659 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18217042 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 2.10999744 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.05736546 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.01944829 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.99155347 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84878121 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.75990454 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75028098 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.67637863 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.65448435 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60982530 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54625790 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53382878 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52211262 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48980662 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.47445905 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46489745 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46471532 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.42376543 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.41900680 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41571089 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38826068 |
| 35 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33613348 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31827733 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17318933 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.15819825 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.15370566 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.15027217 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14165138 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.11572679 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08029019 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07104150 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.04540838 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04062109 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03426647 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97002471 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96787439 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94607091 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94437857 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.90899819 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88081360 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87906651 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86099875 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.81816807 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76154486 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74773723 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.70316624 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68686948 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.67793259 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.64968652 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63128719 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62836652 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62247784 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60357018 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60036169 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59326626 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56000598 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54726867 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54106605 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.52339264 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51130854 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50234068 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47055295 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42866334 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41330546 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40096776 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39798564 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39434674 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39176286 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38960216 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38521396 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35807819 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34044936 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33796031 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33754761 |
| 88 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33619047 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33027484 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31240160 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30855113 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30736970 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30561591 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29918175 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29744373 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28252172 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27806837 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27420374 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26971699 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26702468 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26497869 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.26222737 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22971169 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21969324 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.21932239 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20838678 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.17358149 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16908537 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.16605114 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16119160 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15397184 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14767597 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14487590 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.13065607 |

